Search
Spotlight
In-person and virtual events just for HCPs
In-person and virtual events just for HCPs
Specialty
View More
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
News
OncClub
All Oncology News
Pipeline Report
OncClub
All Oncology News
Pipeline Report
Media
Insights
Medical World News
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Insights
Medical World News
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Partners
Publications
Oncology Live®
Oncology Fellows
Supplements and Featured Publications
All Publications
Oncology Live®
Oncology Fellows
Supplements and Featured Publications
All Publications
CME/CE
Resources
Interactive Tools
Learning Modules
Presentations
Sponsored
Interactive Tools
Learning Modules
Presentations
Sponsored
Biomarker Consortium
Subscribe
Search
Spotlight
In-person and virtual events just for HCPs
Specialty
See All >
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Expert Perspectives on the Latest Advancements in Breast Cancer
EP. 1: ESR Mutations and Resistance to Endocrine Therapy in Breast Cancer
June 23rd 2016
EP. 2: CDK4/6 Inhibitors in Hormone Receptor-Driven MBC
June 23rd 2016
EP. 3: FDA Breakthrough Status for Abemaciclib
June 23rd 2016
EP. 4: The Ongoing Role of Everolimus in ER-Positive MBC
June 23rd 2016
EP. 5: The Emerging Role of PI3K Inhibition in Breast Cancer
June 23rd 2016
EP. 6: What is New for HER2 MBC?
June 23rd 2016
EP. 7: Adjuvant TDM-1 and the KRISTINE Trial
June 23rd 2016
EP. 8: PHEREXA Trial in HER2+ Disease
June 23rd 2016
EP. 9: The Emerging Role of Neratinib in HER2+ MBC
June 23rd 2016
EP. 10: Patient Selection for Neratinib in Metastatic Breast Cancer
June 23rd 2016
EP. 11: Neratinib and HER2 Activating Mutations in Breast Cancer
June 23rd 2016
EP. 12: Biosimilar Trastuzumab in HER2-Positive Breast Cancer
June 23rd 2016
EP. 13: Is There a Role for TNBC Subtyping?
June 23rd 2016
EP. 14: Immunotherapy for TNBC
June 23rd 2016
EP. 15: Adjuvant Therapy for Breast Cancer
June 23rd 2016
EP. 16: AC versus TaxAC in High-Risk HER2-Negative MBC
June 23rd 2016
EP. 17: Practice-Changing Results from the MINDACT Trial
June 23rd 2016
EP. 18: Final Thoughts on Advanced Breast Cancer
June 23rd 2016